Decisions 4th March 2014


  

Recent JFG Decisions

 

At the meeting on the 4th Macrh 2014 the following decisions / changes to the formulary were agreed

 

New Drug Requests

Approved

 

Acid Citrate Dextrose for use with Cell Saver  

  • Approved for inclusion onto the formulary for use as an anticoagulant solutiong for use with Cell Saver machine.

Plasma-Lyte 148 

  • NBT only restriction removed. 

 

Rejected

 

Timolol for paediatric haemangioma

  • Rejected on the grounds of insufficient evidence in this patient cohort to be available for routine prescribing. 

Memantine for Nystagmus

  • Rejected on the grounds of insufficient evidence in this patient cohort to be available for routine prescribing.  

Ibopamine eye drops for abnormally low intraocular pressure

  • Rejected on the grounds of insufficient evidence in this patient cohort to be available for routine prescribing. 

Deferred

 

Relvar

  • More discussion required.  The JFG discussed the application at the meeting, and agreed for inclusion onto the formulary.   However further discussion at the April JFG regarding the possible issues with the colour of the inhlaer in accordance with MTRAC verdict.  

 

Specialised Commissioning

 

None

 

Shared Care Protocols

 

Ranolazine

  • TLS change from Red to amber 3 months.  New SCP, Approved

 

 

Last updated by: on 06-05-2014 13:20